SEDASLEEP

Land: Australien

Sprache: Englisch

Quelle: Department of Health (Therapeutic Goods Administration)

Wirkstoff:

Passiflora incarnata, Quantity: 125 mg (Equivalent: Passiflora incarnata, Qty 500 mg); Humulus lupulus, Quantity: 23.34 mg (Equivalent: Humulus lupulus, Qty 175 mg)

Verfügbar ab:

Bioplus Healthcare Pty Ltd

Darreichungsform:

Tablet, uncoated

Zusammensetzung:

Excipient Ingredients: microcrystalline cellulose; colloidal anhydrous silica; magnesium stearate; maltodextrin; crospovidone; lecithin

Verabreichungsweg:

Oral

Anwendungsgebiete:

Traditionally used in Western herbal medicine to Decrease/reduce/relieve restlessness/excess nervous energy ; Traditionally used in Western herbal medicine to Decrease/reduce/relieve nervous tension/unrest ; Traditionally used in Western herbal medicine to Calmative/nervous system relaxant ; Traditionally used in Western herbal medicine to Nervine/support nervous system ; Traditionally used in Western herbal medicine to Soporific/induces sleep ; Traditionally used in Western herbal medicine to Decrease/reduce/relieve sleeplessness ; Traditionally used in Western herbal medicine to Decrease/reduce/relieve disturbed/restless sleep

Produktbesonderheiten:

Visual Identification: ;

Berechtigungsstatus:

Listed

Berechtigungsdatum:

2020-12-11